Treatment Related


An open label study of oral transmucosal fentanyl citrate (OFTC) for the treatment of breakthrough cancer pain
Breakthrough pain: definition, prevalence and characteristics
Dexamethasone Alone or in Combination with Ondansetron for the Prevention of Delayed Nausea and Vomiting Induced by Chemotherapy
Diagnostic Testing Following Fecal Occult Blood Screening in the Elderly
Effect of Intracoronary (gamma)-Radiation Therapy on In-Stent Restenosis: An Intravascular Ultrasound Analysis from the Gamma-1 Study
Evaluating the Financial Impact of Clinical Trials in Oncology: Results From a Pilot Study From the Association of American Cancer Institutes/Northwestern University Clinical Trials Costs and Charges Project
Long-Term Safety of Oral Transmucosal Fentanyl Citrate for Breakthrough Cancer Pain
Management of Breakthrough Pain Due to Cancer
Once-Weekly Dosing of Epoetin-α Increases Hemoglobin and Improves Quality of Life in Anemic Cancer Patients Receiving Radiation Therapy Either Concomitantly or Sequentially with Chemotherapy
Oral Transmucosal Fentanyl Citrate: Randomized, Double-Blinded, Placebo-Controlled Trial for Treatment of Breakthrough Pain in Cancer Patients
Radiation Therapy in the Management of Desmoid Tumors
Use of Complementary and Alternative Medicine by Cancer Patients Is Not Associated with Perceived Distress or Poor Compliance with Standard Treatment but with Active Coping Behavior